Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Wilson Liao
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Wilson Liao
Dr. Liao is Professor and Vice Chair of Research in the UCSF Department of Dermatology. He serves as Director of the UCSF Psoriasis and Skin Treatment Center and is deeply engaged in patient care, clinical trials, and translational research.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT03293030
- Phase
- Phase 4 Atopic Dermatitis (Eczema) Research Study
- Study Type
- Interventional
- Participants
- Expecting 15 study participants
- Last Updated